Please assess the completion status of the following clinical trial:

Trial Title: Diagnostic Performance of an Antigen Test for SARS-CoV-2 Infection (COVID-19)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Acutely ill with one or more COVID-19 symptoms~Exclusion Criteria:~* Unable to speak English~* Unable to provide written informed consent~* Symptoms have lasted longer than 5 days~* Currently hospitalized

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Study Population (Type: OTHER): All subjects will undergo bilateral mid-turbinate swabs for COVID Antigen (Quidel Sofia SARS Antigen Fluorescent Immunoassay (FIA)) as well as bilateral rt-PCR testing (Quest SARS-CoV-2 rRT-PCR).

Based on this trial design, predict the completion outcome and termination type (if applicable).